New developments in pharmacotherapy for Friedreich ataxia

ABSTRACTIntroduction: Friedreich ataxia (FRDA), a rare disease caused by the deficiency of the mitochondrial matrix protein frataxin, affects roughly 1 in 50,000 individuals worldwide. Current and ...